Banque Pictet & Cie SA Grows Position in SPDR S&P Biotech ETF $XBI

Banque Pictet & Cie SA boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 24.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 64,877 shares of the exchange traded fund’s stock after buying an additional 12,595 shares during the period. Banque Pictet & Cie SA owned approximately 0.09% of SPDR S&P Biotech ETF worth $7,910,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the stock. AQR Capital Management LLC increased its position in shares of SPDR S&P Biotech ETF by 77.1% during the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after acquiring an additional 2,167 shares during the last quarter. Edgestream Partners L.P. acquired a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter worth approximately $526,000. Quantbot Technologies LP boosted its position in shares of SPDR S&P Biotech ETF by 9.9% during the 2nd quarter. Quantbot Technologies LP now owns 47,650 shares of the exchange traded fund’s stock worth $3,952,000 after purchasing an additional 4,311 shares during the period. Twin Peaks Wealth Advisors LLC acquired a new stake in SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $32,000. Finally, CW Advisors LLC increased its holdings in SPDR S&P Biotech ETF by 2.3% in the 2nd quarter. CW Advisors LLC now owns 22,517 shares of the exchange traded fund’s stock valued at $1,867,000 after purchasing an additional 496 shares during the last quarter.

SPDR S&P Biotech ETF Stock Up 0.6%

Shares of NYSEARCA XBI opened at $128.55 on Thursday. The business’s 50 day moving average is $125.03 and its two-hundred day moving average is $117.89. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $132.09. The firm has a market cap of $8.59 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.